Evidence map›Paper›PMID 21124806›Full record

ArticlePloS one2010

Notch and MAML-1 complexation do not detectably alter the DNA binding specificity of the transcription factor CSL.

Cristina Del Bianco, Anastasia Vedenko, Sung Hee Choi, Michael F Berger, Leila Shokri, Martha L Bulyk, Stephen C Blacklow

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Biophysics of Notch Signaling.Annual review of biophysics · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Cristina Del BiancoDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.
Anastasia Vedenko
Sung Hee Choi
Michael F Berger
Leila Shokri
Martha L Bulyk
Stephen C Blacklow
Harvard University · USBrigham and Women's Hospital · US

Funding

Structure and Function in Notch SignalingR01CA092433 · NCI · HARVARD MEDICAL SCHOOL · PI BLACKLOW, STEPHEN C. · 2002 to 2016
$5.0M
Universal, Compact Combinatorial Microarrays for DNA Binding Site DiscoveryR01HG003985 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI BULYK, MARTHA L · 2006 to 2017
$4.9M
NCI NIH HHS R01 CA092433NHGRI NIH HHS R01 HG003985
6 · The paper itself

Abstract

backgroundCanonical Notch signaling is initiated when ligand binding induces proteolytic release of the intracellular part of Notch (ICN) from the cell membrane. ICN then travels into the nucleus where it drives the assembly of a transcriptional activation complex containing the DNA-binding transcription factor CSL, ICN, and a specialized co-activator of the Mastermind family. A consensus DNA binding site motif for the CSL protein was previously defined using selection-based methods, but whether subsequent association of Notch and Mastermind-like proteins affects the DNA binding preferences of CSL has not previously been examined. PRINCIPAL

findingsHere, we utilized protein-binding microarrays (PBMs) to compare the binding site preferences of isolated CSL with the preferred binding sites of CSL when bound to the CSL-binding domains of all four different human Notch receptors. Measurements were taken both in the absence and in the presence of Mastermind-like-1 (MAML1). Our data show no detectable difference in the DNA binding site preferences of CSL before and after loading of Notch and MAML1 proteins. CONCLUSIONS/SIGNIFICANCE: These findings support the conclusion that accrual of Notch and MAML1 promote transcriptional activation without dramatically altering the preferred sites of DNA binding, and illustrate the potential of PBMs to analyze the binding site preferences of multiprotein-DNA complexes.

Indexed as

AlgorithmsBase SequenceBinding, CompetitiveBinding SitesDNADNA-Binding ProteinsGlutathione TransferaseHumansImmunoglobulin J Recombination Signal Sequence-Binding ProteinMicroarray AnalysisOligonucleotidesProtein BindingProto-Oncogene ProteinsReceptor, Notch1Receptor, Notch2Receptor, Notch3DNADNA-Binding ProteinsGlutathione TransferaseImmunoglobulin J Recombination Signal Sequence-Binding ProteinMAML1 protein, humanNOTCH1 protein, humanNOTCH2 protein, humanNOTCH3 protein, humanNOTCH4 protein, humanOligonucleotidesProto-Oncogene ProteinsRBPJ protein, humanReceptor, Notch1Receptor, Notch2Receptor, Notch3Receptor, Notch4Receptors, NotchRecombinant Fusion ProteinsTranscription Factors

Identifiers

PMID21124806
PMCPMC2991368
OpenAlexW1996929497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.